The bronchial challenge with D. pteronyssinus enhanced pro-proliferative properties of inflammatory eosinophils subtype in allergic asthma patients
E. Jurkeviciute (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), B. Tamasauskaite (Kaunas, Lithuania), I. Janulaityte (Kaunas, Lithuania), V. Kalinauskaite-Zukauske (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania)
Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Jurkeviciute (Kaunas, Lithuania), A. Januskevicius (Kaunas, Lithuania), A. Rimkunas (Kaunas, Lithuania), J. Palacionyte (Kaunas, Lithuania), B. Tamasauskaite (Kaunas, Lithuania), I. Janulaityte (Kaunas, Lithuania), V. Kalinauskaite-Zukauske (Kaunas, Lithuania), K. Malakauskas (Kaunas, Lithuania). The bronchial challenge with D. pteronyssinus enhanced pro-proliferative properties of inflammatory eosinophils subtype in allergic asthma patients. 695
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Bronchial challenge with D. pteronyssinus changes the ratio of blood eosinophil subtypes and their biological properties in allergic asthma patients Source: Virtual Congress 2020 – Novel molecular markers and targets for asthma phenotypes Year: 2020
Peripheral blood neutrophil activity during D. pteronyssinus induced late-phase airway inflammation in asthma and rhinitis patients Source: Annual Congress 2012 - Asthma and COPD: understanding through mechanisms Year: 2012
Allergen activates eosinophils of atopic bronchial asthma patients via IgE-mediated mechanism. Source: Virtual Congress 2020 – New insight into the pathogenesis of chronic lung diseases: asthma, COPD and others Year: 2020
Changes in lung functions and inflammatory markers in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2005; 26: Suppl. 49, 734s Year: 2005
The effect of Der f-induced airway inflammation on airway inflammation in a murine model of allergic asthma Source: Eur Respir J 2004; 24: Suppl. 48, 348s Year: 2004
Comparison of late allergic inflammatory responses in asthma and rhinitis after nasal and bronchial allergen challenge Source: Eur Respir J 2001; 18: Suppl. 33, 269s Year: 2001
Humoral markers of inflammation in induced sputum of patients with bronchial asthma and allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2004; 24: Suppl. 48, 595s Year: 2004
A single nasal allergen challenge increases induced sputum inflammatory parameters in non-asthmatic patients with seasonal allergic rhinitis Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001
Effect of amiophylline on airway inflammation induced by Dermatophagoides farinae and intraepithelial dentric cells of airway in murine model Source: Eur Respir J 2005; 26: Suppl. 49, 580s Year: 2005
Correlation between nasal eosinophilic inflammation and bronchial reactivity to methacholine in allergic children sensitized to house dust mites (HDM) Source: Eur Respir J 2002; 20: Suppl. 38, 172s Year: 2002
Markers of inflammation and airway responses to allergen in asthmatic patients Source: Annual Congress 2008 - Asthma: growing understanding of influential factors Year: 2008
The role of mast cells in allergic, non-allergic and aspirin-induced asthma and rhinitis Source: Eur Respir J 2005; 26: Suppl. 49, 589s Year: 2005
Eosinophil degranulation status in allergic rhinitis: observations before and during seasonal allergen exposure Source: Eur Respir J 2004; 24 : 750-757 Year: 2004
Inflammatory markers in induced sputum of patients with allergic rhinitis in relation to exposure to pollen allergens Source: Eur Respir J 2006; 28: Suppl. 50, 444s Year: 2006
Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice Source: Eur Respir J 2009; 34: 200-208 Year: 2009
Biological role of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
A role of fungal extracts on allergic airway inflammation in the ovalbumin-induced asthma model Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
The development of an airway hyperresponsiveness (AHR) depends on mast cells following sensitization without adjuvant Source: Annual Congress 2006 - Cellular immunology in asthma pathogenesis Year: 2006
Experimental specific immunotherapy with timpol decreases allergic sensitization and airway inflammation in murine model of bronchial asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010